Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
- PMID: 17214099
Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Abstract
Background: Monoclonal gammopathy of undetermined significance is defined by the presence of: low serum and/or urine monoclonal protein level; less than 10% plasma cells in bone marrow; normal serum calcium, creatinine and hemoglobinlevels; and no bone lesions on full skeletal X-ray survey.
Objectives: To study the necessity of bone marrow examination for the diagnosis and clinical course of MGUS.
Methods: We retrospectively screened the medical records of all patients in whom monoclonal protein was found in the serum during 2001-2002 in the medical laboratories of Meir Medical Center. Asymptomatic patients who had serum monoclonal immunoglobulin G < 3.0 g/dl or IgA < 2.0 g/dl or IgM < 1.0 g/dl without anemia, renal failure, hypercalcemia or any bone lesions on skeletal survey were eligible. Full records of patients who were evaluated in the hematology clinic were available (group 1). The remaining patients were followed by their family physicians; thus we had access only to their electronic files including laboratory results and new diagnoses (group 2). Demographic and clinical parameters as well as clinical course werewere evaluated.
Results: Both groups (57 and 255 patients, respectively) had similar demographic, laboratory and clinical characteristics. Bone marrow examination was performed in 30 of 57 patients (group 1): 16 were normal, 8 had an excess of normal plasma cells, and 6 had excess of pathologic plasma cells. However, only in two of the latter six could a diagnosis of multiple myeloma be established. All group 1 patients were followed for 22 +/- 11 months and onlytwo developed overt multiple myeloma. During the same period, 6 of 255 patients (group 2) were diagnosed as multiple myeloma and 3 as MGUS in other hospitals. The rest had a stable course with no change in their laboratory values.
Conclusions: Our findings suggest that bone marrow examination should not be performed routinely in patients who fulfill strict clinical and laboratory criteria of MGUS.
Similar articles
-
Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.Haematologica. 2001 Aug;86(8):837-43. Haematologica. 2001. PMID: 11522540
-
HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.Clin Infect Dis. 2006 Nov 1;43(9):1198-205. doi: 10.1086/508351. Epub 2006 Oct 2. Clin Infect Dis. 2006. PMID: 17029142
-
Diagnostic criteria of multiple myeloma.Hematol Oncol Clin North Am. 1992 Apr;6(2):347-58. Hematol Oncol Clin North Am. 1992. PMID: 1582977 Review.
-
Biclonal gammopathy in multiple myeloma: a case report.Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:544-8. Gan To Kagaku Ryoho. 2000. PMID: 10895208
-
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22. Hematol Oncol Clin North Am. 2014. PMID: 25212882 Review.
Cited by
-
Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry.Clin Epidemiol. 2013 Aug 27;5:321-6. doi: 10.2147/CLEP.S50757. eCollection 2013. Clin Epidemiol. 2013. PMID: 24009431 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous